| 1 |
34318583 |
10.1111/aos.14993 |
2022 |
Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. |
CD70 |
| 2 |
34726773 |
10.1002/cncr.34005 |
2022 |
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma. |
CD70 |
| 3 |
34872108 |
10.1182/bloodadvances.2021005714 |
2022 |
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models. |
CD70 |
| 4 |
35041763 |
10.1111/bjd.21018 |
2022 |
Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome. |
CD70 |
| 5 |
35266562 |
10.1002/ajh.26523 |
2022 |
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. |
CD70 |
| 6 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
CD70 |
| 7 |
35443163 |
10.1016/j.celrep.2022.110713 |
2022 |
A single-cell atlas of diffuse large B cell lymphoma. |
CD70 |
| 8 |
35687490 |
10.1182/bloodadvances.2021006654 |
2022 |
Genomic characterization of lymphomas in patients with inborn errors of immunity. |
CD70 |
| 9 |
35787399 |
10.1016/j.jid.2022.06.005 |
2022 |
The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion. |
CD70 |
| 10 |
36055572 |
10.1016/j.clim.2022.109105 |
2022 |
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma. |
CD70 |
| 11 |
33666760 |
10.1007/s00262-021-02895-7 |
2021 |
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy. |
CD70 |
| 12 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
CD70 |
| 13 |
33996677 |
10.3389/fped.2021.615724 |
2021 |
Specific Immune Response and Cytokine Production in CD70 Deficiency. |
CD70 |
| 14 |
33996698 |
10.3389/fped.2021.662645 |
2021 |
Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies. |
CD70 |
| 15 |
34189576 |
10.1182/blood.2020010527 |
2021 |
SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma. |
CD70 |
| 16 |
34267181 |
10.1038/s41408-021-00521-4 |
2021 |
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. |
CD70 |
| 17 |
34638238 |
10.3390/cancers13194752 |
2021 |
Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection. |
CD70 |
| 18 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
CD70 |
| 19 |
32298986 |
10.1016/j.tranon.2020.100770 |
2020 |
Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma. |
CD70 |
| 20 |
32380537 |
10.1182/bloodadvances.2019001079 |
2020 |
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. |
CD70 |
| 21 |
32439996 |
10.1038/s41598-020-65463-6 |
2020 |
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL. |
CD70 |
| 22 |
32451662 |
10.1007/s10875-020-00790-x |
2020 |
An Update on XMEN Disease. |
CD70 |
| 23 |
32603431 |
10.1182/blood.2020006738 |
2020 |
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. |
CD70 |
| 24 |
32620996 |
10.1007/s10875-020-00816-4 |
2020 |
Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect. |
CD70 |
| 25 |
33162537 |
10.11406/rinketsu.61.1365 |
2020 |
[Lymphoproliferative disorders and inborn errors of immunity]. |
CD70 |
| 26 |
29800648 |
10.1016/j.jaci.2018.04.030 |
2019 |
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. |
CD70 |
| 27 |
30132271 |
10.1007/s10637-018-0655-0 |
2019 |
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma. |
CD70 |
| 28 |
30784598 |
10.1016/j.celrep.2019.01.085 |
2019 |
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4<sup>+</sup> T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma. |
CD70 |
| 29 |
31292525 |
10.1038/s41598-019-46473-5 |
2019 |
Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL. |
CD70 |
| 30 |
31402499 |
10.1111/imr.12791 |
2019 |
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases. |
CD70 |
| 31 |
31597848 |
10.11406/rinketsu.60.1229 |
2019 |
[The immune microenvironment in malignant lymphoma]. |
CD70 |
| 32 |
31652572 |
10.3390/cancers11101611 |
2019 |
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method. |
CD70 |
| 33 |
31678777 |
10.1016/j.scr.2019.101612 |
2019 |
Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation. |
CD70 |
| 34 |
31867275 |
10.3389/fonc.2019.01350 |
2019 |
CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma. |
CD70 |
| 35 |
29282224 |
10.15252/emmm.201708292 |
2018 |
Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility. |
CD70 |
| 36 |
29311309 |
10.1073/pnas.1713607115 |
2018 |
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses. |
CD70 |
| 37 |
29564225 |
10.3389/fonc.2018.00054 |
2018 |
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. |
CD70 |
| 38 |
28011863 |
10.1084/jem.20160784 |
2017 |
Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. |
CD70 |
| 39 |
28011864 |
10.1084/jem.20160849 |
2017 |
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. |
CD70 |
| 40 |
28495792 |
10.1182/blood-2016-12-756585 |
2017 |
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. |
CD70 |
| 41 |
28783700 |
10.1126/sciimmunol.aan0291 |
2017 |
It's all in the family. |
CD70 |
| 42 |
29158380 |
10.1073/pnas.1710877114 |
2017 |
Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. |
CD70 |
| 43 |
26077361 |
10.3109/10428194.2015.1063140 |
2016 |
Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients. |
CD70 |
| 44 |
26914723 |
10.1517/14728222.2016.1158812 |
2016 |
Therapeutic targeting of CD70 and CD27. |
CD70 |
| 45 |
25582824 |
10.1038/mt.2015.4 |
2015 |
Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression. |
CD70 |
| 46 |
24569779 |
10.1038/leu.2014.84 |
2014 |
TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin's lymphoma. |
CD70 |
| 47 |
25142258 |
10.1007/s10637-014-0151-0 |
2014 |
Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma. |
CD70 |
| 48 |
25171927 |
10.1182/blood-2013-12-546309 |
2014 |
Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. |
CD70 |
| 49 |
22801960 |
10.3324/haematol.2012.068791 |
2013 |
Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. |
CD70 |
| 50 |
23206232 |
10.1111/bjh.12136 |
2013 |
Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27. |
CD70 |
| 51 |
23716461 |
10.1002/gcc.22072 |
2013 |
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma. |
CD70 |
| 52 |
23808985 |
10.1021/bc400217g |
2013 |
A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology. |
CD70 |
| 53 |
21994111 |
10.1002/pbc.23352 |
2012 |
Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection. |
CD70 |
| 54 |
22213068 |
10.1002/ijc.27416 |
2012 |
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas. |
CD70 |
| 55 |
21182090 |
10.1002/eji.201040905 |
2011 |
CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes. |
CD70 |
| 56 |
19806404 |
10.1007/s11307-009-0264-6 |
2010 |
Two-step in vivo tumor targeting by biotin-conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T. |
CD70 |
| 57 |
19346216 |
10.1074/mcp.M800515-MCP200 |
2009 |
Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma. |
CD70 |
| 58 |
19386499 |
10.1016/j.bmcl.2009.03.145 |
2009 |
Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system. |
CD70 |
| 59 |
19509224 |
10.1158/0008-5472.CAN-09-0266 |
2009 |
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma. |
CD70 |
| 60 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
CD70 |
| 61 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
CD70 |
| 62 |
19047103 |
10.1158/1078-0432.CCR-08-0493 |
2008 |
Preclinical characterization of SGN-70, a humanized antibody directed against CD70. |
CD70 |
| 63 |
17038522 |
10.1182/blood-2006-07-034017 |
2007 |
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities. |
CD70 |
| 64 |
17615291 |
10.1182/blood-2007-03-082578 |
2007 |
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. |
CD70 |
| 65 |
16275070 |
10.1016/j.bmcl.2005.09.081 |
2006 |
Dipeptide-based highly potent doxorubicin antibody conjugates. |
CD70 |
| 66 |
16704224 |
10.1021/bc0600214 |
2006 |
Development and properties of beta-glucuronide linkers for monoclonal antibody-drug conjugates. |
CD70 |
| 67 |
18528464 |
NA |
2006 |
Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors. |
CD70 |
| 68 |
16272354 |
10.4049/jimmunol.175.10.6940 |
2005 |
Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma. |
CD70 |
| 69 |
16373719 |
10.1158/1535-7163.MCT-05-0253 |
2005 |
Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas. |
CD70 |
| 70 |
15359114 |
10.1023/B:JOCI.0000040926.37275.3b |
2004 |
Resistance to cytotoxic chemotherapy is induced by NK cells in non-Hodgkin's Lymphoma Cells. |
CD70 |
| 71 |
12421908 |
10.4049/jimmunol.169.10.5377 |
2002 |
Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. |
CD70 |
| 72 |
12472567 |
10.1046/j.1365-2141.2002.03931.x |
2002 |
Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. |
CD70 |
| 73 |
11333903 |
10.1128/JVI.75.11.5215-5221.2001 |
2001 |
Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. |
CD70 |
| 74 |
10800994 |
10.1097/00000478-200005000-00014 |
2000 |
CD70 expression in thymic carcinoma. |
CD70 |
| 75 |
10221513 |
10.3109/10428199909058433 |
1999 |
Modulation of costimulatory molecules on follicular lymphoma cells by TNF and CD40. |
CD70 |
| 76 |
10419648 |
10.1006/cyto.1998.0449 |
1999 |
CD27 signals through PKC in human B cell lymphomas. |
CD70 |
| 77 |
10444164 |
10.1046/j.1365-2141.1999.01474.x |
1999 |
Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells. |
CD70 |
| 78 |
10460611 |
10.1046/j.1365-2141.1999.01573.x |
1999 |
Aberrant expression and reverse signalling of CD70 on malignant B cells. |
CD70 |
| 79 |
10527687 |
10.1006/clim.1999.4782 |
1999 |
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. |
CD70 |
| 80 |
9850023 |
10.1200/JCO.1998.16.12.3788 |
1998 |
Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. |
CD70 |
| 81 |
9354461 |
NA |
1997 |
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. |
CD70 |
| 82 |
11725067 |
10.1007/BF02255217 |
1995 |
Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas. |
CD70 |
| 83 |
8580081 |
10.1093/intimm/7.11.1827 |
1995 |
A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70. |
CD70 |
| 84 |
27457195 |
10.3109/10428199009050972 |
1990 |
Detection of Activation Antigens on Chronic Lymphocytic Leukaemia Cells. |
CD70 |
Datasets
Models
